Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2003
10/09/2003WO2002040676A3 Mutant allergens
10/09/2003WO2002038797A3 Modulators of bruton's tyrosine kinase, their identification and use
10/09/2003WO2002035229A3 Method for the identification of apoptotic and necrotic cells
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002031188A3 Method and device for predicting haplotypes
10/09/2003WO2002027027A8 Method of screening for therapeutics for infectious diseases
10/09/2003WO2002024940A3 Means for the identification of compounds capable of inhibiting karap-transduced signals
10/09/2003WO2002022854A3 Method for the detection and measurement of biomass
10/09/2003WO2002022664A3 Antigenic proteins of shrimp white spot syndrome virus and uses thereof
10/09/2003WO2002021418A3 Method and system for identifying commercially distributed organisms
10/09/2003WO2002020563A3 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN
10/09/2003WO2002016636A3 Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders
10/09/2003WO2002016612A3 Genes and proteins, and their uses
10/09/2003WO2002014545A3 Method for determining weather a test compound binds to a large rna target
10/09/2003WO2002012290A3 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
10/09/2003WO2002010755A3 Organ transplant rejection and associated conditions
10/09/2003WO2002010382A3 Trp8, trp9 and trp10, markers for cancer
10/09/2003WO2002008451A3 Assay for screening compounds for inducing drug metabolizing enzymes
10/09/2003WO2001071027A3 mRNA AMPLIFICATION
10/09/2003US20030191415 Integrated sample testing meter
10/09/2003US20030191405 Sidestream gas sampling system with detachable sample cell
10/09/2003US20030191299 PRO polypeptides fused to heterologous polypeptide sequences
10/09/2003US20030191290 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191289 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191288 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191287 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191284 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191282 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191281 Of given amino acid sequence; culturing host cells transformed with vector
10/09/2003US20030191280 Class ii cytokine receptor-7
10/09/2003US20030191136 Melanin concentrating hormone receptor ligands
10/09/2003US20030191114 Binding to ligand; induce signals
10/09/2003US20030191083 Screening, detection microbiocides; sepsis, rheumatic diseases, antiarthritic agents; bactericides
10/09/2003US20030191078 Prevent reproduction of oligonucleotides
10/09/2003US20030191063 Peptide selection method
10/09/2003US20030191062 Bone marrow specific protein
10/09/2003US20030191058 Anticancer agents; antiinflammatory agents
10/09/2003US20030191048 Gene expression profile for KSHV infection and methods for treating same
10/09/2003US20030190760 Reducing non-specific binding in immunoassays performed on polymeric solid phases
10/09/2003US20030190759 Controls velocity of sample; adhesion and liquid transportation force by capillary phenomenon
10/09/2003US20030190758 Detecting sampling in capillary tube; solidification; analyzing, classification
10/09/2003US20030190749 Expression element that comprises a gene linked to sequences that are inducible and/or repressible; mutations; useful in diagnositics, therapeutics and drug discovery
10/09/2003US20030190744 Method and apparatus for performing biological reactions on a substrate surface
10/09/2003US20030190740 Protease and peptidase-resistant proteins; Drug screening for control of cell division, apoptosis; for cancer treatment
10/09/2003US20030190739 Tankyrase2 materials and methods
10/09/2003US20030190737 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
10/09/2003US20030190731 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190730 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190729 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190728 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190727 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190726 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190725 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190724 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190723 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190722 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190721 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190720 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190719 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190718 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190717 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190716 Used to produce pharmaceuticals, diagnostics, biosensors, bioreactors; PRO polypeptides
10/09/2003US20030190709 Modulation apoptosis; Alzheimer's diseases; Parkinson's disease; amyotropic lateral sclerosis
10/09/2003US20030190707 17 human secreted proteins
10/09/2003US20030190702 Used to treat human malignancies associated with heregulin-mediated cell growth such as breast and prostate cancer
10/09/2003US20030190699 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190698 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190693 Identifying inhibitors and activators of eukaryotic potassium channels
10/09/2003US20030190692 Method for measuring the activity of the blood clotting factor XIIIA
10/09/2003US20030190691 Involves detecting and quantifying the existence of an alteration of the serum protein albumin following an ischemic event
10/09/2003US20030190690 A dry-type biosensor ; comprises a sample introductory part, a space forming material, a sample holding part, a developing layer a marker reagent holding part, a reagent immobilization part and a retiform structure
10/09/2003US20030190689 Identifying the most relevant signal transduction pathway biomarkers of disease progression, outcome, or therapeutic responsiveness
10/09/2003US20030190688 Methods for detecting BCR-ABL signaling activity in tissues using phospho-specific antibodies
10/09/2003US20030190686 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmacetical compositions containing such compounds
10/09/2003US20030190685 Bind to Tumor Necrosis Factor(TNF)-Related Apoptosis Inducing Ligand (TRAIL) receptors ; used in the prevention and treatment of cancers and other proliferative disorders
10/09/2003US20030190684 Multiparameter facs assays to detect alterations in cellular parameters and to screen small molecule libraries
10/09/2003US20030190683 Minicell-based rational drug design
10/09/2003US20030190682 Preparation of immunostimulatory vaccines with activated antigen presenting cells which stimulate a therapeutic T cells response in vivo; used to treat cancer
10/09/2003US20030190681 Flow cytometer for analysis of general diagnostic factors in cells and body fluids
10/09/2003US20030190678 Comprising measuring the concentration of human lipocalin-type prostaglandin D synthase in a sample of a body fluid
10/09/2003US20030190676 In which covalently modified antibody takes on the binding specificity of a targeting agent
10/09/2003US20030190674 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
10/09/2003US20030190673 Method for optical detection of an adjoining of a material component to a sensor material with the aid of biological, chemical or physical interaction and device for carrying out said method (variants)
10/09/2003US20030190671 Includes administering a probe substrate specific to metabolic pathway(s) for a class of N-(arylsubstituted)-naphthalidimides ; detecting metabolites of the pathway(s); characterizing respective phenotypic determinants based on metabolites
10/09/2003US20030190669 Humanized antibody.
10/09/2003US20030190668 Identification and isolation of DNA and recombinant production of polypeptides
10/09/2003US20030190667 Identification and isolation of DNA and recombinant production of polypeptides
10/09/2003US20030190663 Novel assay for nucleic acid analysis
10/09/2003US20030190660 Compositions and methods for detecting and quantifying gene expression
10/09/2003US20030190657 Rafiki model and map to the genetic code
10/09/2003US20030190656 Prognosticating metastasis in a breast cancer patient by identifying differential modulation of each gene selected from a group; gene expression portfolios and kits
10/09/2003US20030190655 Involves genetically marked organisms, a database server, a method for assigning sequences to genetically mark organisms and for book keeping data pertaining to the marked organisms and/or their owner, producer or source
10/09/2003US20030190653 Regulated gene in the pathophysiology of ischemic stroke
10/09/2003US20030190652 Methods of validating SNPs and compiling libraries of assays
10/09/2003US20030190651 Preventing, ameliorating, correcting dysfunctions or diseases such as cancer, peripheral and central nervous system diseases, and chronic obstructive pulmonary disease
10/09/2003US20030190650 Identifying a gene product which modulates the transition of a cell between a non-apoptopic state and an apoptopic state; granulocyte macrophage colony stimulating factor (GM-CSF); tyrosine phosphorylation;
10/09/2003US20030190649 Annotating Single Nucleotide Polymorphism (SNP) onto candidate genes based on appropriate sequence comparison software or algorithms of SNP databases; selecting intragenic SNPs for genotyping
10/09/2003US20030190646 Methods for detecting target nucleic acids using coupled ligation and amplification
10/09/2003US20030190644 Methods for generating databases and databases for identifying polymorphic genetic markers
10/09/2003US20030190643 Sequencing by mass spectrometry
1 ... 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 ... 3937